Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Taiji Miyake und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan. Electronic address: miyake.…. Hauptthemen laut MEDLINE: Glucuronosyltransferase, Hepatocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chugai Pharmaceutical.
Abstract (Originalsprache)
Drug clearance and drug-drug interactions are essential for pharmacokinetic assessment. However, current in vitro systems and animal scale-up approaches often fail to accurately predict drug disposition mediated by metabolizing enzymes, especially uridine diphosphate-glucuronosyltransferase (UGT). This study demonstrates how UGT-mediated drug disposition in humans can be predicted using hu-PXB mice (cDNA-uPA/severe combined immunodeficiency (SCID) mice transplanted with human-derived hepatocytes). To estimate human hepatic intrinsic clearance (CLh,int) in vitro, UGT substrates (acetaminophen, entacapone, ketoprofen, lorazepam, oxazepam, posaconazole, and zidovudine) were incubated with cryopreserved human hepatocytes. CLh,int was calculated based on the rate of substrate disappearance. In vivo human CLh,int values were calculated based on literature. To evaluate human CLh,int predictability, the 7 substrates were administered independently and intravenously to hu-PXB and SCID mice. We calculated the CLh,int in the mice and compared it with that in humans. For predicting UGT-mediated drug-drug interactions, 2 UGT substrates were administered intravenously to hu-PXB mice with or without probenecid (a UGT inhibitor). We compared the changes in clearance with those in humans. The in vitro assay using hepatocytes significantly underpredicted CLh,int in humans. Hu-PXB mice had a much better correlation with humans in CLh,int (R2 = 0.95) compared with SCID mice (R2 = 0.69). Hu-PXB mice predicted the CLh,int of UGT substrate drugs within 2-fold of the clinical values for every compound we evaluated. The decrease in clearance caused by probenecid in hu-PXB mice reflected that in humans. Our findings demonstrate that human drug disposition mediated by UGT can be predicted based on the in vivo studies using hu-PXB mice. SIGNIFICANCE STATEMENT: Human liver chimeric mice can accurately predict the clearance of uridine diphosphate-glucuronosyltransferase (UGT) substrate drugs and are likely to predict the magnitude of UGT-mediated drug-drug interactions. Findings from in vivo studies in humanized mice enable the selection of better candidates in drug discovery and allow for the more precise physiologically based pharmacokinetic modeling of UGT substrate drugs in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan. Electronic address: miyake.taiji61@chugai-pharm.co.jp.
- Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan.
- Experimental Technology Department, Chugai Research Institute for Medical Science Inc., Yokohama-shi, Japan.
- Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan. Electronic address: tachibanatth@chugai-pharm.co.jp.
Förderung
- Chugai Pharmaceutical
Zitieren
APA
Miyake, T., Fujita, Y., Hirabayashi, M., Komiyama, N., Morita, K., Tachibana, T., & Terao, K. (2025). Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100050
Vancouver
Miyake T, Fujita Y, Hirabayashi M, Komiyama N, Morita K, Tachibana T, et al. Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100050
BibTeX
@article{Miyake2025,
author = {Miyake, Taiji and Fujita, Yuito and Hirabayashi, Manabu and Komiyama, Natsuko and Morita, Keiichi and Tachibana, Tatsuhiko and Terao, Kimio},
title = {Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100050}
}
EUVIMED